Research use only. For in-vitro and laboratory research. Not for human or veterinary use. No aliquoting guidance is provided.

AOD-9604 Research Video Explainer

Out of stock at the moment. The video is still here to watch.

This short video explains AOD-9604 as a research compound. AOD-9604 is Tyrosine-Modified C-Terminal hGH(177-191) Lipolytic Hexadecapeptide. It covers its molecular identity (CAS 221231-10-3, 1815.08 g/mol) and the pathways studied in laboratory models. For in-vitro and laboratory research use only. Not for human or veterinary use.

Identity

What researchers study it for

• Studying selective adipocyte lipolysis and inhibition of de novo lipogenesis without full hGH receptor activation.
• Confirming absence of IGF-1 upregulation, mitogenic proliferation or insulin-antagonistic diabetogenic effects.
• Investigating beta-3 adrenergic receptor (ADRB3) expression and hormone-sensitive lipase (HSL) phosphorylation.

How it is studied to work

• 1. Non-GHR Lipolytic Domain Action N-terminal Tyr177-stabilised cyclic disulfide loop (Cys182-Cys189) acts independently of the full hGH receptor.
• 2. Beta-3 Adrenergic & HSL Activation Up-regulates adipocyte beta-3 adrenergic receptors and stimulates PKA-mediated HSL phosphorylation.
• 3. Lipolysis Without IGF-1 Elevation Accelerates glycerol and free fatty-acid release while leaving hepatic IGF-1 and glucose transport unchanged.

Lab links

Verify your batch All peptide videos

Related research videos

• HGH Fragment 176-191 research video
• Adipotide (FTTP) research video
• 5-Amino-1MQ research video
• All 164 peptide research videos

Corex Vitality™ supplies research peptides for laboratory use only. This page is an educational explainer of molecular identity and published research pathways. It is not medical advice and does not recommend human use.